When considering patients for a major hepatectomy, one must carefully consider the volume of liver to be left behind and if additional procedures are necessary to augment its volume. This review considers the optimal volume of the future liver remnant (FLR) and analyzes the techniques of augmenting this volume, the various growth parameters to assess adequate growth of the FLR, as well as further management when there has been inadequate growth of the FLR.
BozzettiF.DociR.BignamiP.MorabitoA.GennariL. Patterns of failure following surgical resection of colorectal cancer liver metastases. rationale for a multimodal approach. Ann Surg. 1987;205(3):264-270.doi:10.1097/00000658-198703000-00008
2.
EkbergH.TranbergKG.AnderssonRet al. Pattern of recurrence in liver resection for colorectal secondaries. World J Surg. 1987;11(4):541-546.doi:10.1007/BF01655821
3.
BeppuT.MiyamotoY.SakamotoYet al. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival. Ann Surg Oncol. 2014;21 (Suppl 3):405-413.doi:10.1245/s10434-014-3577-x
4.
PulitanòC.BodingbauerM.AldrighettiLet al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol. 2011;18(5):1380-1388.doi:10.1245/s10434-010-1459-4
5.
AdamsRB.AloiaTA.LoyerEet al. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB. 2013;15(2):91-103.doi:10.1111/j.1477-2574.2012.00557.x
6.
VautheyJ-N.AbdallaEK.DohertyDAet al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl. 2002;8(3):233-240.doi:10.1053/jlts.2002.31654
7.
KawasakiS.MakuuchiM.MatsunamiHet al. Preoperative measurement of segmental liver volume of donors for living related liver transplantation. Hepatology. 1993;18(5):1115-1120.doi:10.1002/hep.1840180516
8.
RiberoD.AbdallaEK.MadoffDCet al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg. 2007;94(11):1386-1394.doi:10.1002/bjs.5836
9.
ShindohJ.TrutyMJ.AloiaTAet al. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg. 2013;216(2):201-209.doi:10.1016/j.jamcollsurg.2012.10.018
10.
SchnitzbauerAA.LangSA.GoessmannHet al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255(3):405-414.doi:10.1097/SLA.0b013e31824856f5
11.
de SantibañesE.ClavienP-A. Playing Play-Doh to prevent postoperative liver failure: the "ALPPS" approach. Ann Surg. 2012;255(3):415-417.doi:10.1097/SLA.0b013e318248577d
12.
MakuuchiM.ThaiBL.TakayasuKet al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107(5):521-527.
13.
KishiY.AbdallaEK.ChunYSet al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg. 2009;250(4):540-548.doi:10.1097/SLA.0b013e3181b674df
14.
Morris-StiffG.TanY-M.VautheyJN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol. 2008;34(6):609-614.doi:10.1016/j.ejso.2007.07.007
15.
ShindohJ.TzengC-WD.AloiaTAet al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013;20(8):2493-2500.doi:10.1245/s10434-012-2864-7
16.
AzoulayD.CastaingD.SmailAet al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231(4):480-486.doi:10.1097/00000658-200004000-00005
17.
KubotaK.MakuuchiM.KusakaKet al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology. 1997;26(5):1176-1181.doi:10.1053/jhep.1997.v26.pm0009362359
18.
ClavienP-A.PetrowskyH.DeOliveiraML.GrafR. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356(15):1545-1559.doi:10.1056/NEJMra065156
19.
MazzaferroV.RegaliaE.DociRet al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693-700.doi:10.1056/NEJM199603143341104
20.
KinoshitaH.SakaiK.HirohashiKet al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 1986;10(5):803-808.doi:10.1007/BF01655244
21.
AbulkhirA.LimongelliP.HealeyAJet al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49-57.doi:10.1097/SLA.0b013e31815f6e5b
22.
KoHK.KoG-Y.SungK-B.GwonD-I.YoonH-K. Portal vein embolization via percutaneous Transsplenic access prior to major hepatectomy for patients with insufficient future liver remnant. J Vasc Interv Radiol. 2016;27(7):981-986.doi:10.1016/j.jvir.2016.03.022
23.
SarwarA.BrookOR.WeinsteinJL.KhwajaK.AhmedM. Trans-splenic portal vein embolization: a technique to avoid damage to the future liver remnant. Cardiovasc Intervent Radiol. 2016;39(10):1514-1518.doi:10.1007/s00270-016-1359-5
24.
GongGQ.WangXL.WangJHet al. Percutaneous transsplenic embolization of esophageal and gastrio-fundal varices in 18 patients. World J Gastroenterol. 2001;7(6):880-883.doi:10.3748/wjg.v7.i6.880
25.
HabibA.DesaiK.HickeyRet al. Portal vein recanalization-transjugular intrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol. 2015;26(4):499-506.doi:10.1016/j.jvir.2014.12.012
SalemR.VoucheM.BakerTet al. Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis. Transplantation. 2015;99(11):2347-2355.doi:10.1097/TP.0000000000000729
28.
DollingerM.GoessmannH.Mueller-WilleRet al. Percutaneous transhepatic and transsplenic portal vein access: embolization of the puncture tract using amplatzer vascular plugs. Rofo. 2014;186(2):142-150.doi:10.1055/s-0033-1350514
29.
de BaereT.RocheA.VavasseurDet al. Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology. 1993;188(1):73-77.doi:10.1148/radiology.188.1.8511321
30.
de BaereT.RocheA.EliasDet al. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;24(6):1386-1391.doi:10.1002/hep.510240612
31.
ImamuraH.ShimadaR.KubotaMet al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology. 1999;29(4):1099-1105.doi:10.1002/hep.510290415
32.
ShimamuraT.NakajimaY.UneYet al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery. 1997;121(2):135-141.doi:10.1016/S0039-6060(97)90282-8
SalemR.MazzaferroV.SangroB. Yttrium 90 radioembolizationfor treatment of hepatocelluar carcinoma in the United States. Hepatology. 2013;58:2188-2197.
35.
KimRD.KimJS.WatanabeG.MohuczyD.BehrnsKE. Liver regeneration and the atrophy-hypertrophy complex. Semin Intervent Radiol. 2008;25(2):092-103.doi:10.1055/s-2008-1076679
36.
TeoJ-Y.AllenJC.NgDCet al. A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90. HPB. 2016;18(1):7-12.doi:10.1016/j.hpb.2015.07.002
37.
CloydJM.AloiaTA. Hammer versus Swiss army knife: developing a strategy for the management of bilobar colorectal liver metastases. Surgery. 2017;162(1):12-17.doi:10.1016/j.surg.2016.11.035
38.
KishiY.MadoffDC.AbdallaEKet al. Is embolization of segment 4 portal veins before extended right hepatectomy justified?Surgery. 2008;144(5):744-751.doi:10.1016/j.surg.2008.05.015
39.
GruttadauriaS.GridelliB. Sequential preoperative ipsilateral portal and arterial embolization in patients with liver tumors: is it really the best approach?World J Surg. 2007;31(12):2427-2428.doi:10.1007/s00268-007-9239-4
40.
NaginoM.KanaiM.MoriokaAet al. Portal and arterial embolization before extensive liver resection in patients with markedly poor functional reserve. J Vasc Interv Radiol. 2000;11(8):1063-1068.doi:10.1016/S1051-0443(07)61340-2
41.
HwangS.LeeS-G.KoG-Yet al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy. Ann Surg. 2009;249(4):608-616.doi:10.1097/SLA.0b013e31819ecc5c
42.
HwangS.HaT-Y.KoG-Yet al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy. World J Surg. 2015;39(12):2990-2998.doi:10.1007/s00268-015-3194-2
43.
GuiuB.ChevallierP.DenysAet al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol. 2016;26(12):4259-4267.doi:10.1007/s00330-016-4291-9
44.
ClavienPA.de SantibañesE. The ALPPS: time to explore!Ann Surg. 2012;256(3):e18-e19.
45.
AloiaTA.VautheyJ-N. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): what is gained and what is lost?Ann Surg. 2012;256(3):e9doi:10.1097/SLA.0b013e318265fd3e
46.
AndrianiOC. Long-term results with associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Ann Surg. 2012;256(3):e5.doi:10.1097/SLA.0b013e318265fbbe
47.
ConradC.ShivathirthanN.CamerloA.StraussC.GayetB. Laparoscopic portal vein ligation with in situ liver split for failed portal vein embolization. Ann Surg. 2012;256(3):e14-e15.doi:10.1097/SLA.0b013e318265ff44
48.
ErginaPL.CookJA.BlazebyJMet al. Challenges in evaluating surgical innovation. Lancet. 2009;374(9695):1097-1104.doi:10.1016/S0140-6736(09)61086-2
49.
BarkunJS.AronsonJK.FeldmanLSet al. Evaluation and stages of surgical innovations. Lancet. 2009;374(9695):1089-1096.doi:10.1016/S0140-6736(09)61083-7
50.
TschuorC.CroomeKP.SergeantGet al. Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion – an extension of the ALPPS approach. Eur J Surg Oncol. 2013;39(11):1230-1235.doi:10.1016/j.ejso.2013.08.009
51.
SchaddeE.ArdilesV.SlankamenacKet al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis. World J Surg. 2014;38(6):1510-1519.doi:10.1007/s00268-014-2513-3
52.
SchaddeE.ArdilesV.Robles-CamposRet al. Early survival and safety of ALPPS: first report of the International ALPPS registry. Ann Surg. 2014;260(5):829-836.doi:10.1097/SLA.0000000000000947
53.
LineckerM.StavrouGA.OldhaferKJet al. The ALPPS risk score: avoiding futile use of ALPPS. Ann Surg. 2016;264(5):763-771.doi:10.1097/SLA.0000000000001914
54.
OlthofPB.HuiskensJ.WichertsDAet al. Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: a case-matched comparison with palliative systemic therapy. Surgery. 2017;161(4):909-919.doi:10.1016/j.surg.2016.10.032
55.
LangH.de SantibanesE.ClavienPA. Outcome of ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the International ALPPS registry. HPB. 2017;19(5):379-380.doi:10.1016/j.hpb.2017.01.024
56.
LineckerM.BjörnssonB.StavrouGAet al. Risk adjustment in ALPPS is associated with a dramatic decrease in early mortality and morbidity. Ann Surg. 2017;266(5):779-786.doi:10.1097/SLA.0000000000002446
57.
EnneM.SchaddeE.BjörnssonBet al. ALPPS as a salvage procedure after insufficient future liver remnant hypertrophy following portal vein occlusion. HPB. 2017;19(12):1126-1129.doi:10.1016/j.hpb.2017.08.013
